Marotta Asset Management Novo Nordisk A S Transaction History

Marotta Asset Management

$497 Million
Q2 2025

A detailed history of Marotta Asset Management transactions in Novo Nordisk A S stock. As of the latest transaction made, Marotta Asset Management holds 14,641 shares of NVO stock, worth $732,489. This represents 0.2% of its overall portfolio holdings.

Number of Shares

14,641

Previous 16,653 12.08%

Holding current value

$732,489

Previous $1.16 Million 12.63%

% of portfolio

0.2%

Previous 0.25%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 02, 2025	SELL	$58.08 - $81.05 $116,856 - $163,072	-2,012 Reduced 12.08%	14,641 $1.01 Million
Q1 2025 Apr 02, 2025	BUY	$69.3 - $90.95 $39,154 - $51,386	565 Added 3.51%	16,653 $1.16 Million
Q4 2024 Jan 10, 2025	SELL	$85.0 - $120.04 $48,025 - $67,822	-565 Reduced 3.39%	16,088 $1.38 Million
Q3 2024 Oct 03, 2024	SELL	$119.07 - $145.42 $32,387 - $39,554	-272 Reduced 1.61%	16,653 $1.98 Million
Q2 2024 Jul 17, 2024	SELL	$122.71 - $146.91 $36,935 - $44,219	-301 Reduced 1.75%	16,925 $2.42 Million
Q1 2024 Apr 02, 2024	SELL	$102.11 - $135.92 $12,048 - $16,038	-118 Reduced 0.68%	17,226 $2.21 Million
Q4 2023 Jan 03, 2024	SELL	$87.78 - $105.45 $13,693 - $16,450	-156 Reduced 0.89%	17,344 $1.79 Million
Q3 2023 Oct 11, 2023	BUY	$90.94 - $199.54 $783,084 - $1.72 Million	8,611 Added 96.87%	17,500 $1.59 Million
Q2 2023 Jul 05, 2023	SELL	$155.98 - $172.65 $8,266 - $9,150	-53 Reduced 0.59%	8,889 $1.44 Million
Q4 2022 Jan 03, 2023	SELL	$102.55 - $135.33 $40,814 - $53,861	-398 Reduced 4.26%	8,942 $0
Q3 2022 Oct 11, 2022	SELL	$95.28 - $116.93 $32,966 - $40,457	-346 Reduced 3.57%	9,340 $930,000
Q2 2022 Jul 21, 2022	SELL	$103.24 - $121.81 $103 - $121	-1 Reduced 0.01%	9,686 $1.08 Million
Q1 2022 Apr 08, 2022	SELL	$93.1 - $112.54 $112,278 - $135,723	-1,206 Reduced 11.07%	9,687 $1.08 Million
Q4 2021 Jan 13, 2022	BUY	$95.88 - $117.08 $76,704 - $93,664	800 Added 7.93%	10,893 $1.22 Million
Q3 2021 Oct 21, 2021	SELL	$84.42 - $106.62 $1,603 - $2,025	-19 Reduced 0.19%	10,093 $969,000
Q2 2021 Jul 09, 2021	BUY	$67.66 - $84.76 $80,718 - $101,118	1,193 Added 13.38%	10,112 $847,000
Q1 2021 Apr 09, 2021	BUY	$67.06 - $75.82 $598,108 - $676,238	8,919 New	8,919 $601,000

Others Institutions Holding NVO

# of Institutions

1,760

Shares Held

338M

Call Options Held

11M

Put Options Held

15.9M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $113B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marotta Asset Management, based on Form 13F filings with the SEC.

News

Stay updated on Marotta Asset Management with notifications on news.

Account

Marotta Asset Management Novo Nordisk A S Transaction History